経口インスリンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Oral Insulin Market Insights, Forecast to 2028

• レポートコード：QY2207E10442 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の経口インスリンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口インスリンの世界市場のxxx％を占める「1型糖尿病」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「女性」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の経口インスリンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの経口インスリン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの経口インスリン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 経口インスリンのグローバル主要メーカーには、Novo Nordisk、Oramed Pharmaceuticals、vTv Therapeutics、Diabetology、Generex Biotechnology、Coromed、Nektar Therapeuticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 経口インスリン市場は、種類と用途によって区分されます。世界の経口インスリン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 1型糖尿病、2型糖尿病 【用途別セグメント】 女性、男性 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 経口インスリン製品概要 - 種類別市場（1型糖尿病、2型糖尿病） - 用途別市場（女性、男性） - 調査の目的 ・エグゼクティブサマリー - 世界の経口インスリン販売量予測2017-2028 - 世界の経口インスリン売上予測2017-2028 - 経口インスリンの地域別販売量 - 経口インスリンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別経口インスリン販売量 - 主要メーカー別経口インスリン売上 - 主要メーカー別経口インスリン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（1型糖尿病、2型糖尿病） - 経口インスリンの種類別販売量 - 経口インスリンの種類別売上 - 経口インスリンの種類別価格 ・用途別市場規模（女性、男性） - 経口インスリンの用途別販売量 - 経口インスリンの用途別売上 - 経口インスリンの用途別価格 ・北米市場 - 北米の経口インスリン市場規模（種類別、用途別） - 主要国別の経口インスリン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの経口インスリン市場規模（種類別、用途別） - 主要国別の経口インスリン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の経口インスリン市場規模（種類別、用途別） - 主要国別の経口インスリン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の経口インスリン市場規模（種類別、用途別） - 主要国別の経口インスリン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの経口インスリン市場規模（種類別、用途別） - 主要国別の経口インスリン市場規模（トルコ、サウジアラビア） ・企業情報 Novo Nordisk、Oramed Pharmaceuticals、vTv Therapeutics、Diabetology、Generex Biotechnology、Coromed、Nektar Therapeutics ・産業チェーン及び販売チャネル分析 - 経口インスリンの産業チェーン分析 - 経口インスリンの原材料 - 経口インスリンの生産プロセス - 経口インスリンの販売及びマーケティング - 経口インスリンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 経口インスリンの産業動向 - 経口インスリンのマーケットドライバー - 経口インスリンの課題 - 経口インスリンの阻害要因 ・主な調査結果

The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
Market Analysis and Insights: Global Oral Insulin Market
Due to the COVID-19 pandemic, the global Oral Insulin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Type 1 Diabetes accounting for % of the Oral Insulin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Female segment is altered to an % CAGR throughout this forecast period.
China Oral Insulin market size is valued at US$ million in 2021, while the US and Europe Oral Insulin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Insulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Oral Insulin include Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed and Nektar Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oral Insulin Scope and Segment
Oral Insulin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Segment by Application
Female
Male
By Company
Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Oral Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Oral Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.3 Market by Application
1.3.1 Global Oral Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Female
1.3.3 Male
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Insulin Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Insulin Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Insulin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Insulin Sales by Region
2.4.1 Global Oral Insulin Sales by Region (2017-2022)
2.4.2 Global Sales Oral Insulin by Region (2023-2028)
2.5 Global Oral Insulin Revenue by Region
2.5.1 Global Oral Insulin Revenue by Region (2017-2022)
2.5.2 Global Oral Insulin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Insulin Sales by Manufacturers
3.1.1 Global Top Oral Insulin Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Insulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Insulin in 2021
3.2 Global Oral Insulin Revenue by Manufacturers
3.2.1 Global Oral Insulin Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Insulin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Insulin Revenue in 2021
3.3 Global Oral Insulin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Insulin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Insulin Sales by Type
4.1.1 Global Oral Insulin Historical Sales by Type (2017-2022)
4.1.2 Global Oral Insulin Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Insulin Sales Market Share by Type (2017-2028)
4.2 Global Oral Insulin Revenue by Type
4.2.1 Global Oral Insulin Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Insulin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Insulin Revenue Market Share by Type (2017-2028)
4.3 Global Oral Insulin Price by Type
4.3.1 Global Oral Insulin Price by Type (2017-2022)
4.3.2 Global Oral Insulin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Insulin Sales by Application
5.1.1 Global Oral Insulin Historical Sales by Application (2017-2022)
5.1.2 Global Oral Insulin Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Insulin Sales Market Share by Application (2017-2028)
5.2 Global Oral Insulin Revenue by Application
5.2.1 Global Oral Insulin Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Insulin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Insulin Revenue Market Share by Application (2017-2028)
5.3 Global Oral Insulin Price by Application
5.3.1 Global Oral Insulin Price by Application (2017-2022)
5.3.2 Global Oral Insulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Insulin Market Size by Type
6.1.1 North America Oral Insulin Sales by Type (2017-2028)
6.1.2 North America Oral Insulin Revenue by Type (2017-2028)
6.2 North America Oral Insulin Market Size by Application
6.2.1 North America Oral Insulin Sales by Application (2017-2028)
6.2.2 North America Oral Insulin Revenue by Application (2017-2028)
6.3 North America Oral Insulin Market Size by Country
6.3.1 North America Oral Insulin Sales by Country (2017-2028)
6.3.2 North America Oral Insulin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral Insulin Market Size by Type
7.1.1 Europe Oral Insulin Sales by Type (2017-2028)
7.1.2 Europe Oral Insulin Revenue by Type (2017-2028)
7.2 Europe Oral Insulin Market Size by Application
7.2.1 Europe Oral Insulin Sales by Application (2017-2028)
7.2.2 Europe Oral Insulin Revenue by Application (2017-2028)
7.3 Europe Oral Insulin Market Size by Country
7.3.1 Europe Oral Insulin Sales by Country (2017-2028)
7.3.2 Europe Oral Insulin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Insulin Market Size by Type
8.1.1 Asia Pacific Oral Insulin Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Insulin Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Insulin Market Size by Application
8.2.1 Asia Pacific Oral Insulin Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Insulin Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Insulin Market Size by Region
8.3.1 Asia Pacific Oral Insulin Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Insulin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral Insulin Market Size by Type
9.1.1 Latin America Oral Insulin Sales by Type (2017-2028)
9.1.2 Latin America Oral Insulin Revenue by Type (2017-2028)
9.2 Latin America Oral Insulin Market Size by Application
9.2.1 Latin America Oral Insulin Sales by Application (2017-2028)
9.2.2 Latin America Oral Insulin Revenue by Application (2017-2028)
9.3 Latin America Oral Insulin Market Size by Country
9.3.1 Latin America Oral Insulin Sales by Country (2017-2028)
9.3.2 Latin America Oral Insulin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Oral Insulin Market Size by Type
10.1.1 Middle East and Africa Oral Insulin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Insulin Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Insulin Market Size by Application
10.2.1 Middle East and Africa Oral Insulin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Insulin Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Insulin Market Size by Country
10.3.1 Middle East and Africa Oral Insulin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Insulin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Oramed Pharmaceuticals
11.2.1 Oramed Pharmaceuticals Corporation Information
11.2.2 Oramed Pharmaceuticals Overview
11.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Oramed Pharmaceuticals Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Oramed Pharmaceuticals Recent Developments
11.3 vTv Therapeutics
11.3.1 vTv Therapeutics Corporation Information
11.3.2 vTv Therapeutics Overview
11.3.3 vTv Therapeutics Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 vTv Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 vTv Therapeutics Recent Developments
11.4 Diabetology
11.4.1 Diabetology Corporation Information
11.4.2 Diabetology Overview
11.4.3 Diabetology Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Diabetology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Diabetology Recent Developments
11.5 Generex Biotechnology
11.5.1 Generex Biotechnology Corporation Information
11.5.2 Generex Biotechnology Overview
11.5.3 Generex Biotechnology Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Generex Biotechnology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Generex Biotechnology Recent Developments
11.6 Coromed
11.6.1 Coromed Corporation Information
11.6.2 Coromed Overview
11.6.3 Coromed Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Coromed Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Coromed Recent Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Corporation Information
11.7.2 Nektar Therapeutics Overview
11.7.3 Nektar Therapeutics Oral Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Nektar Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nektar Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Insulin Industry Chain Analysis
12.2 Oral Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Insulin Production Mode & Process
12.4 Oral Insulin Sales and Marketing
12.4.1 Oral Insulin Sales Channels
12.4.2 Oral Insulin Distributors
12.5 Oral Insulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Insulin Industry Trends
13.2 Oral Insulin Market Drivers
13.3 Oral Insulin Market Challenges
13.4 Oral Insulin Market Restraints
14 Key Findings in The Global Oral Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Oral Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Type 1 Diabetes
Table 3. Major Manufacturers of Type 2 Diabetes
Table 4. Global Oral Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oral Insulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral Insulin Sales by Region (2017-2022) & (K Units)
Table 7. Global Oral Insulin Sales Market Share by Region (2017-2022)
Table 8. Global Oral Insulin Sales by Region (2023-2028) & (K Units)
Table 9. Global Oral Insulin Sales Market Share by Region (2023-2028)
Table 10. Global Oral Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral Insulin Revenue Market Share by Region (2017-2022)
Table 12. Global Oral Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Oral Insulin Revenue Market Share by Region (2023-2028)
Table 14. Global Oral Insulin Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Oral Insulin Sales Share by Manufacturers (2017-2022)
Table 16. Global Oral Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oral Insulin Revenue Share by Manufacturers (2017-2022)
Table 18. Oral Insulin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Oral Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oral Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Insulin as of 2021)
Table 21. Oral Insulin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oral Insulin Product Offered
Table 23. Date of Manufacturers Enter into Oral Insulin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Insulin Sales by Type (2017-2022) & (K Units)
Table 26. Global Oral Insulin Sales by Type (2023-2028) & (K Units)
Table 27. Global Oral Insulin Sales Share by Type (2017-2022)
Table 28. Global Oral Insulin Sales Share by Type (2023-2028)
Table 29. Global Oral Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oral Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Oral Insulin Revenue Share by Type (2017-2022)
Table 32. Global Oral Insulin Revenue Share by Type (2023-2028)
Table 33. Oral Insulin Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Oral Insulin Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Oral Insulin Sales by Application (2017-2022) & (K Units)
Table 36. Global Oral Insulin Sales by Application (2023-2028) & (K Units)
Table 37. Global Oral Insulin Sales Share by Application (2017-2022)
Table 38. Global Oral Insulin Sales Share by Application (2023-2028)
Table 39. Global Oral Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oral Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Oral Insulin Revenue Share by Application (2017-2022)
Table 42. Global Oral Insulin Revenue Share by Application (2023-2028)
Table 43. Oral Insulin Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Oral Insulin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Oral Insulin Sales by Type (2017-2022) & (K Units)
Table 46. North America Oral Insulin Sales by Type (2023-2028) & (K Units)
Table 47. North America Oral Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oral Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Oral Insulin Sales by Application (2017-2022) & (K Units)
Table 50. North America Oral Insulin Sales by Application (2023-2028) & (K Units)
Table 51. North America Oral Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oral Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Oral Insulin Sales by Country (2017-2022) & (K Units)
Table 54. North America Oral Insulin Sales by Country (2023-2028) & (K Units)
Table 55. North America Oral Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oral Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Oral Insulin Sales by Type (2017-2022) & (K Units)
Table 58. Europe Oral Insulin Sales by Type (2023-2028) & (K Units)
Table 59. Europe Oral Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oral Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Oral Insulin Sales by Application (2017-2022) & (K Units)
Table 62. Europe Oral Insulin Sales by Application (2023-2028) & (K Units)
Table 63. Europe Oral Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oral Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Oral Insulin Sales by Country (2017-2022) & (K Units)
Table 66. Europe Oral Insulin Sales by Country (2023-2028) & (K Units)
Table 67. Europe Oral Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oral Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Oral Insulin Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Oral Insulin Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Oral Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oral Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oral Insulin Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Oral Insulin Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Oral Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oral Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oral Insulin Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Oral Insulin Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Oral Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oral Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Oral Insulin Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Oral Insulin Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Oral Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oral Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Oral Insulin Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Oral Insulin Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Oral Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oral Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Oral Insulin Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Oral Insulin Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Oral Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oral Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Oral Insulin Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Oral Insulin Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Oral Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oral Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oral Insulin Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Oral Insulin Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Oral Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oral Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oral Insulin Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Oral Insulin Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Oral Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oral Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Novo Nordisk Corporation Information
Table 106. Novo Nordisk Description and Major Businesses
Table 107. Novo Nordisk Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Novo Nordisk Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Novo Nordisk Recent Developments
Table 110. Oramed Pharmaceuticals Corporation Information
Table 111. Oramed Pharmaceuticals Description and Major Businesses
Table 112. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Oramed Pharmaceuticals Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Oramed Pharmaceuticals Recent Developments
Table 115. vTv Therapeutics Corporation Information
Table 116. vTv Therapeutics Description and Major Businesses
Table 117. vTv Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. vTv Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. vTv Therapeutics Recent Developments
Table 120. Diabetology Corporation Information
Table 121. Diabetology Description and Major Businesses
Table 122. Diabetology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Diabetology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Diabetology Recent Developments
Table 125. Generex Biotechnology Corporation Information
Table 126. Generex Biotechnology Description and Major Businesses
Table 127. Generex Biotechnology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Generex Biotechnology Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Generex Biotechnology Recent Developments
Table 130. Coromed Corporation Information
Table 131. Coromed Description and Major Businesses
Table 132. Coromed Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Coromed Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Coromed Recent Developments
Table 135. Nektar Therapeutics Corporation Information
Table 136. Nektar Therapeutics Description and Major Businesses
Table 137. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Nektar Therapeutics Oral Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Nektar Therapeutics Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Oral Insulin Distributors List
Table 143. Oral Insulin Customers List
Table 144. Oral Insulin Market Trends
Table 145. Oral Insulin Market Drivers
Table 146. Oral Insulin Market Challenges
Table 147. Oral Insulin Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Insulin Product Picture
Figure 3. Global Oral Insulin Market Share by Type in 2021 & 2028
Figure 3. Type 1 Diabetes Product Picture
Figure 4. Type 2 Diabetes Product Picture
Figure 5. Global Oral Insulin Market Share by Application in 2021 & 2028
Figure 6. Female
Figure 7. Male
Figure 8. Oral Insulin Report Years Considered
Figure 9. Global Oral Insulin Sales 2017-2028 (K Units)
Figure 10. Global Oral Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Oral Insulin Revenue 2017-2028 (US$ Million)
Figure 12. Global Oral Insulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Oral Insulin Sales Market Share by Region (2017-2022)
Figure 14. Global Oral Insulin Sales Market Share by Region (2023-2028)
Figure 15. North America Oral Insulin Sales YoY (2017-2028) & (K Units)
Figure 16. North America Oral Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Oral Insulin Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Oral Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Oral Insulin Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Oral Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Oral Insulin Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Oral Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Oral Insulin Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Oral Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Oral Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Oral Insulin in the World: Market Share by Oral Insulin Revenue in 2021
Figure 27. Global Oral Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Oral Insulin Sales Market Share by Type (2017-2028)
Figure 29. Global Oral Insulin Revenue Market Share by Type (2017-2028)
Figure 30. Global Oral Insulin Sales Market Share by Application (2017-2028)
Figure 31. Global Oral Insulin Revenue Market Share by Application (2017-2028)
Figure 32. North America Oral Insulin Sales Market Share by Type (2017-2028)
Figure 33. North America Oral Insulin Revenue Market Share by Type (2017-2028)
Figure 34. North America Oral Insulin Sales Market Share by Application (2017-2028)
Figure 35. North America Oral Insulin Revenue Market Share by Application (2017-2028)
Figure 36. North America Oral Insulin Sales Share by Country (2017-2028)
Figure 37. North America Oral Insulin Revenue Share by Country (2017-2028)
Figure 38. United States Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Oral Insulin Sales Market Share by Type (2017-2028)
Figure 41. Europe Oral Insulin Revenue Market Share by Type (2017-2028)
Figure 42. Europe Oral Insulin Sales Market Share by Application (2017-2028)
Figure 43. Europe Oral Insulin Revenue Market Share by Application (2017-2028)
Figure 44. Europe Oral Insulin Sales Share by Country (2017-2028)
Figure 45. Europe Oral Insulin Revenue Share by Country (2017-2028)
Figure 46. Germany Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 47. France Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Oral Insulin Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Oral Insulin Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Oral Insulin Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Oral Insulin Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Oral Insulin Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Oral Insulin Revenue Share by Region (2017-2028)
Figure 57. China Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 60. India Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Oral Insulin Sales Market Share by Type (2017-2028)
Figure 67. Latin America Oral Insulin Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Oral Insulin Sales Market Share by Application (2017-2028)
Figure 69. Latin America Oral Insulin Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Oral Insulin Sales Share by Country (2017-2028)
Figure 71. Latin America Oral Insulin Revenue Share by Country (2017-2028)
Figure 72. Mexico Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Oral Insulin Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Oral Insulin Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Oral Insulin Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Oral Insulin Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Oral Insulin Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Oral Insulin Revenue Share by Country (2017-2028)
Figure 82. Turkey Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Oral Insulin Revenue (2017-2028) & (US$ Million)
Figure 85. Oral Insulin Value Chain
Figure 86. Oral Insulin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---